Rapid Antifungal Susceptibility Testing and Diagnostics of Antifungal Resistance
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 30 April 2026 | Viewed by 43
Special Issue Editor
Interests: epidemiology; antifungal resistance; yeast infections; candidemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Invasive fungal infections remain an underrecognized health problem, compounded by diagnostic challenges and the growing emergence of resistance to the limited antifungal agents currently available. Epidemiological data indicate a worldwide rise in severe mycosis, with over 150 million cases and an estimated 1.7 million deaths annually (Vitiello et al., 2023).
Emerging species such as Nakaseomyces glabratus, Pichia kudriavzevii, and Candida auris, have become increasingly important pathogens due to their intrinsic and acquired resistance to antifungal agents. In particular, C. auris is a multidrug-resistant pathogen that poses a significant global threat to human health. Developing improved diagnostic tools and targeted antifungal strategies is critical to preserving drug effectiveness.
This Special Issue focuses on antimicrobial resistance, including antifungal resistance. Topics of interest include the development of new antifungal drugs, advances in understanding resistance mechanisms, novel in vitro susceptibility data, and innovative strategies to combat fungal infections. Together, these contributions aim to advance the knowledge necessary to address antifungal resistance effectively.
Dr. Valentina Salas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antifungal resistance
- drug resistance mechanisms
- multidrug resistance
- intrinsic resistance and acquired resistance
- new resistant opportunistic fungi
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
